PT  - JOURNAL ARTICLE
ED  - Leon, Martin B.
TI  - One-Year Data from the RESOLUTE US Trial
DP  - 2011 Jun 01
TA  - MD Conference Express
PG  - 14--15
VI  - 11
IP  - 3
4099  - http://mdc.sagepub.com/content/11/3/14.short
4100  - http://mdc.sagepub.com/content/11/3/14.full
AB  - Drug-eluting stents (DES) are commonly used to treat coronary artery disease, because they reduce in-stent thrombosis and the need for repeat revascularization compared with bare-metal stents. However, there are safety concerns regarding the infrequent but life-threatening complication of stent thrombosis. Further development of DES with sustained drug release is hypothesized to represent an even safer alternative.